Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $303.91M.
ENTERPRISE VALUE (EV)
$303.91M
Opus Genetics, Inc.
Market Cap
$349.01M
Enterprise Value (EV)
$303.91M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Opus Genetics, Inc. (IRD) | $349.01M | $303.91M |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $351.32M | $373.55M |
| Embecta Corp. (EMBC)vs › | $351.97M | $1.64B |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $354.67M | $313.42M |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.25M | $49.65M |
| ClearPoint Neuro, Inc. (CLPT)vs › | $333.18M | $367.77M |
| Agenus Inc. (AGEN)vs › | $333.14M | $355.11M |
| Canopy Growth Corporation (CGC)vs › | $370.48M | $328.74M |
| Cabaletta Bio, Inc. (CABA)vs › | $322.03M | $122.65M |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.20M | $299.45M |
Market Cap
$349.01M
Total Debt
$0.00
Cash
$45.09M
Enterprise Value
$303.91M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
